What is BCM-95 and who cares? you might ask...
""Six-month, Randomized, Placebo-Controlled, Double-Blind, Pilot Clinical Trial of Curcumin in Patients with Alzheimer Disease," Baum L, Wai Kei Lam C, et al, Journal of Clinical Psychopharmacology, 2008; 28: 110-13. (Address: Larry Baum, Dept of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong. E-mail: firstname.lastname@example.org ).
Summary: In a 6-month, randomized, double-blind, placebo-controlled pilot clinical trial involving 22 patients with Alzheimer's disease, supplementation with a particular curcumin supplement (BCM-95 capsules) was found to have significantly greater bioavailability, as compared to conventional curcumin powder, suggesting it may provide better clinical benefits. Subjects (aged 50 years of age or older) with progressive decline in memory or cognitive function, diagnosed with probable or possible Alzheimer's disease were given: 1.0 g/d curcumin, 4.0 g/d curcumin, or placebo, taken after a meal (capsules) or mixed with food (powder), for a period of 6 months. Supplementation with curcumin was found to increase levels of serum Abeta, possibly reflecting the ability of curcumin to disaggregate Abeta deposits in the brain. Significant increases in vitamin E were found as well, with greater increases found among subjects who took the BCM-95 capsulses. In addition, BMC-95 was absorbed 7.8 times more than conventional curcumin; this bioavailability may confer greater clinical benefits. The authors recommend that BCM-95 be used in future clinical trials. A larger trial of a longer duration is warranted."
Geronova Research R-PLUS Curcumin uses the highly bioavailable BCM-95 material. Oh and don't forget, it is on sale now.